Performance & Insight Engineer - Kempston Salary: *GBP*45,091 per annum - *GBP*49,282 per annumBasis: Full timePackage: 37 Hours Per Week, Hybrid Working, Flexitime Scheme, Local Government Pension Scheme, Holiday allowance of 25 days (plus public holidays)
DevOps Software Engineer - Bedford Introduction Saab in UK is growing rapidly, with over 600 colleagues across eight sites. We bring together Swedish heritage and British expertise to drive innovation in areas such as software engineering,
Scientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines which address unmet patient needs
Insight Analyst - Milton Keynes About The Role SALARY: Starting from 29,854.40 pa dependent on experience LOCATION: Milton Keynes HYBRID WORKING: Our current hybrid working policy requires a minimum of 60% of working time to be
Channel Manager - Warranty - Milton Keynes About The Role SALARY: From 69,300 pa dependent on experience LOCATION: Milton Keynes HYBRID WORKING: Our current hybrid working policy requires a minimum of 60% of working time to
Senior Customer Resolutions Executive - Milton Keynes About The Role SALARY: Starting from 27,422.40 pa dependent on experience LOCATION: Milton Keynes HYBRID WORKING: Our current hybrid working policy requires a minimum of 60% of working time
Customer Resolutions Specialist Executive - Milton Keynes About The Role SALARY: Starting from 27,422.40 pa dependent on experience LOCATION: Milton Keynes HYBRID WORKING: Our current hybrid working policy requires a minimum of 60% of working time
Customer Resolutions Executive - Milton Keynes About The Role SALARY: Starting from 26,186 pa dependent on experience LOCATION: Milton Keynes HYBRID WORKING: Our current hybrid working policy requires a minimum of 60% of working time to
Senior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines which address